Informing health system planning for biomarker-based treatment: statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042

DOI: 10.1016/j.lanwpc.2025.101537 Publication Date: 2025-04-06T14:00:22Z